DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Raymond James Maintains Outperform on NeoGenomics, Raises Price Target to $32

Raymond James analyst Andrew Cooper maintains NeoGenomics (NASDAQ:NEO) with a Outperform and raises the price target from $28 to $32.

Benzinga · 03/02/2020 12:20

Raymond James analyst Andrew Cooper maintains NeoGenomics (NASDAQ:NEO) with a Outperform and raises the price target from $28 to $32.